HAI Seattle: Biomarkers Closing in on AD Pathological Sequence?
The earliest pathological underpinnings of Alzheimer disease often precede symptoms by untold numbers of years, presenting researchers with a two-edged sword...
6397 RESULTS
Sort By:
The earliest pathological underpinnings of Alzheimer disease often precede symptoms by untold numbers of years, presenting researchers with a two-edged sword...
Unfortunately, there is no quick test for predicting Alzheimer disease (AD)—at least not yet...
Though PIB has shown great promise as an in-vivo amyloid tracer in brain imaging, it is conceivable the compound does not pick up the full range of pathological Aβ in the brain...
Anyone who has grappled with a garden hose knows that it is much better behaved when it is coiled. The same could be said for DNA...
Mutations in tau cause the protein to aggregate in neurodegenerative diseases, but many conditions evince tau tangles in the absence of tau mutations...
People seem to have a heady relationship with the mental state called delirium...
The γ-secretase has come a long way since its original discovery as the protease responsible for the production of amyloid-β peptides during sequential cleavage of the amyloid precursor protein...
The stutter that causes an overabundance of DNA repeats in diseases such as Huntington’s is tricky to silence because the normal genes, too, have their own, smaller share of repeats...
Figuring out what high levels of brain amyloid mean for otherwise healthy older people was a prime focus of the Human Amyloid Imaging (HAI) conference...
For the past two years, HBO’s award-winning documentary team has been filming and editing a massive project on Alzheimer disease...
HAI Seattle: Does Brain Amyloid Correlate With Sagging Metabolism? HAI Seattle: Aβ May Disrupt Brain Function in Normal Seniors HAI Seattle: Not Just Amyloid, Not Just PIB HAI Seattle: Biomarkers Closing in on AD Pathological Sequence? Human Amyloid Imagi
Alzheimer disease researchers are coming to grips with the possibility that some experimental therapies could be failing because they have been tested in people whose disease is too advanced...
One of the enduring mysteries of Parkinson disease has been the exquisite specificity of neuronal death...
Scientists may have answered the neurological chicken-and-egg question in the case of amyotrophic lateral sclerosis (ALS): Which comes first, the protein aggregates or the disease?...
The nonprofit Prize4Life is awarding two scientific teams with $50,000 each at the American Academy of Neurology annual meeting in Seattle, Washington, this week...
No filters selected